Presynaptic adenosine and P2Y receptors

Handbook of Experimental Pharmacology

Volumn 184, Issue , 2008, Pages 339-372

  Gonçalves, Jorge ^a   Queiroz, Glória ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ADENOSINE RECEPTOR; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; PRESYNAPTIC RECEPTOR; PURINE DERIVATIVE; PURINERGIC P2 RECEPTOR;

ANIMAL; DRUG EFFECT; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW;

ADENOSINE; ANIMALS; HUMANS; NEUROTRANSMITTER AGENTS; PURINES; RECEPTOR, ADENOSINE A1; RECEPTORS, ADENOSINE A2; RECEPTORS, PRESYNAPTIC; RECEPTORS, PURINERGIC P1; RECEPTORS, PURINERGIC P2;

EID: 39349088101     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/978-3-540-74805-2_11     Document Type: Article

References (260)

1. Abbracchio MP, Burnstock G, Boeynaems JM et al (2006) International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58:281-341
2. Abe M, Endoh T, Suzuki T (2003) Extracellular ATP-induced calcium channel inhibition mediated by P1/P2Y purinoceptors in hamster submandibular ganglion neurons. Br J Pharmacol 138:1535-43
3. Akasu T, Hirai K, Koketsu K (1982) Modulatory effect of ATP on the release of acetylcholine from presynaptic nerve terminals in bullfrog sympathetic ganglia. Kurume Med J 29:75-83
4. Allgaier C, Hertting G, Kugelgen OV (1987) The adenosine receptor-mediated inhibition of noradrenaline release possibly involves an N-protein and is increased by α2-autoreceptor blockade. Br J Pharmacol 90:403-12
5. Allgaier C, Greber R, Hertting G (1991) Studies on the interaction between presynaptic α2-adrenoceptors and adenosine A1 receptors located on noradrenergic nerve terminals. Naunyn-Schmiedberg's Arch Pharmacol 344:187-92
6. Ambrosio AF, Malva JO, Carvalho AP et al (1997) Inhibition of N-,P/Q-and other types of Ca2+ channels in rat hippocampal nerve terminals by the adenosine A1 receptor. Eur J Pharmacol 340:301-10
7. Auchampach JA, Jin X, Wan TC et al (1997) Canine mast cell adenosine receptors: cloning and expression of the A3 receptor and evidence that degranulation is mediated by the A2B receptor. Mol Pharmacol 52:846-60
8. Baldwin SA, Mackey JR, Cass CE et al (1999) Nucleoside transporters: molecular biology and implications for therapeutic development. Mol Med Today 5:216-24
9. Barajas-Lopez C, Muller MJ, Prieto-Gomez B et al (1995) ATP inhibits the synaptic release of acetylcholine in submucosal neurons. J Pharmacol Exp Ther 274:1238-45
10. Barraco RA, Clough-Helfman C, Goodwin BP et al (1995) Evidence for presynaptic adenosine A2a receptors associated with norepinephrine release and their desensitization in the rat nucleus tractus solitarius. J Neurochem 65:1604-11
11. Barraco RA, Helfman CC, Anderson GF (1996) Augmented release of serotonin by adenosine A2a receptor activation and desensitization by CGS 21680 in the rat nucleus tractus solitarius. Brain Res 733:155-61
12. Baxter RL, Vega-Riveroll LJ, Deuchars J et al (2005) A2A adenosine receptors are located on presynaptic motor nerve terminals in the mouse. Synapse 57:229-34
13. Bennett GC, Boarder MR (2000) The effect of nucleotides and adenosine on stimulus-evoked glutamate release from rat brain cortical slices. Br J Pharmacol 131:617-23
14. Blackmer T, Larsen EC, Takahashi M et al (2001) G protein β? subunit-mediated presynaptic inhibition: regulation of exocytotic fusion downstream Ca2+ entry. Science 292:293-7
15. Bodin P, Burnstock G (2001) Purinergic signalling: ATP release. Neurochem Res 26:959-69
16. Bohmann C, von Kugelgen I, Rump LC (1997) P2-receptor modulation of noradrenergic neurotransmission in rat kidney. Br J Pharmacol 121:1255-62
17. Bowker HM, Chapman AG (1986) Adenosine analogues. The temperature-dependence of the anticonvulsant effect and inhibition of 3H-D-aspartate release. Biochem Pharmacol 35:2949-53
18. Boyer JL, Mohanram A, Camaioni E et al (1998) Competitive and selective antagonism of P2Y1 receptors by N6-methyl 2-deoxyadenosine 3-,5-biphosphate. Br J Pharmacol 124:1-3
19. Brackett LE, Daly JW (1994) Functional characterization of the A2b adenosine receptor in NIH 3T3 fibroblasts. Biochem Pharmacol 47:801-14
20. Brown DA, Pilippov AK, Branard EA (2000) Inhibition of potassium and calcium currents in neurons by molecularly-defined P2Y receptors. J Auton Nerv Sys 81:31-6
21. Brown SJ, James S, Reddington M et al (1990) Both A1 and A2a purine receptors regulate striatal acetylcholine release. J Neurochem 55:31-8
22. Bucher B, Corriu C, Stoclet JC (1992) Prejunctional opioid receptors and adenosine A1-receptors on the sympathetic nerve endings of the rat-tail artery interact with the α2-adrenoceptors. Naunyn-Schmiedberg's Arch Pharmacol 345:37-43
23. Burnstock G (1976) Do some nerve cells release more than one transmitter? Neuroscience 1:239-48
24. Burnstock G (1978) A basis for distinguishing two types of purinergic receptor. In: Bolis L, Straub RW (eds) Cell Membrane Receptors for Drugs and Hormones. Raven Press, New York, pp 107-18
25. Burnstock G (2004) Cotransmission. Curr Opin Pharmacol 4:47-52
26. Burnstock G, Kennedy C (1985) Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmacol 16:433-40
27. Castillo-Melendez M, Krstew E, Lawrence AJ et al (1994) Presynaptic adenosine A2a receptors on soma and central terminals of rat vagal afferent neurons. Brain Res 652:137-44
28. Ciruela F, Saura C, Canela EI et al (1996) Adenosine deaminase affects ligand-induced signalling by interacting with cell surface adenosine receptors. FEBS Lett 380:219-23
29. Ciruela F, Escriche M, Burgueno J et al (2001) Metabotropic glutamate 1α and adenosine A1 receptors assemble into functionally interacting complexes. J Biol Chem 276:18345-51
30. Ciruela F, Casado V, Rodrigues RJ et al (2006) Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers. J Neurosci 26:2080-7
31. Clanachan AS, Johns A, Paton D M (1977) Presynaptic inhibitory actions of adenine nucleotides and adenosine on the neurotransmission in the rat vas deferens. Neuroscience 2:597-602
32. Communi D, Govaerts C, Parmentier M et al (1997) Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase. J Biol Chem 272:31969-73
33. Corradetti R, Lo Conte G, Moroni F et al (1984) Adenosine decreases aspartate and glutamate release from rat hippocampal slices. Eur J Pharmacol 104:19-26
34. Correia-de-Sa P, Sebastiao AM, Ribeiro JA (1991) Inhibitory and excitatory effects of adenosine receptor agonists on evoked transmitter release from phrenic nerve ending of the rat. Br J Pharmacol 103:1614-20
35. Correia-de-Sa P, Ribeiro JA (1994a) Potentiation by tonic A2a-adenosine receptor activation of CGRP-facilitated [3H]-ACh release from rat motor nerve endings. Br J Pharmacol 111:582-8
36. Correia-de-Sa P, Ribeiro JA (1994b) Tonic adenosine A2A receptor activation modulates nicotinic autoreceptor function at the rat neuromuscular junction. Eur J Pharmacol 271:349-55
37. Correia-de-Sa P, Ribeiro JA (1994c) Evidence that presynaptic A2A-adenosine receptor of the motor nerve endings is positively coupled to adenylate cyclase. Naunyn-Schmiedberg's Arch Pharmacol 350:514-22
38. Correia-de-Sa P, Timoteo MA, Ribeiro JA (1996) Presynaptic A1 inhibitory/A2A facilitatory adenosine receptor activation balance depends on motor nerve stimulation paradigm at the rat hemidiaphragm. J Neurophysiol 76:3910-19
39. Correia-de-Sa P, Timoteo MA, Ribeiro JA (2001) Synergism between A2A-adenosine receptor activation and vasoactive intestinal peptide to facilitate [3H]-acetylcholine release from the rat motor nerve terminals. Neurosci Lett 309:101-4
40. Correia-de-Sa P, Adaes S, TimoteoMAet al (2006) Fine-tuning modulation of myenteric motoneurons by endogenous adenosine: on the role of secreted adenosine deaminase. Auton Neurosci 126-127:211-24
41. Cox SL, Schelb V, Trendelenburg AU et al (2000) Enhancement of noradrenaline release by angiotensin II and bradykinin in mouse atria: evidence for cross talk between Gq/11 protein-and Gi/o protein-coupled receptors. Br J Pharmacol 129:1095-1102
42. Cunha RA, Milusheva E, Vizi ES et al (1994a) Excitatory and inhibitory effects of A1 and A2A adenosine receptor activation on the electrically evoked [3H]acetylcholine release from different areas of the rat hippocampus. J Neurochem 63:207-14
43. Cunha RA, Ribeiro JA, Sebastiao AM (1994b) Purinergic modulation of the evoked release of [3H] acetylcholine from the hippocampus and cerebral cortex of the rat: role of the ectonucleotidases. Eur J Neurosci 6:33-42
44. Cunha RA, Sebastiao AM, Ribeiro JA (1998) Inhibition by ATP of hippocampal synaptic transmission requires localized extracellular catabolism by ecto-nucleotidases into adenosine and channelling to adenosine A1 receptors. J Neurosci 18:1987-95
45. Cunha RA, Ribeiro JA (2000a) Purinergic modulation of [3H]GABA release from rat hippocampal nerve terminals. Neuropharmacology 39:1156-67
46. Cunha RA, Ribeiro JA (2000b) Adenosine A2A receptor facilitation of synaptic transmission in the CA1 area of the rat hippocampus requires protein kinase C but not protein kinase A activation. Neurosci Lett 289:127-30
47. Currie KP, Fox AP (1996) ATP serves as a negative feedback inhibitor of voltage-gated Ca2+ channel currents in cultured bovine adrenal chromaffin cells. Neuron 16:1027-36
48. Decking UKM, Schlieper G, Kroll K, Schrader J (1997) Hypoxia-induced inhibition of adenosine kinase potentiates cardiac adenosine release. Circ Res 81:154-64
49. De Lorenzo S, Veggetti M, Muchnik S et al (2006) Presynaptic inhibition of spontaneous acetylcholine release mediated by P2Y receptors at the mouse neuromuscular junction. Neuroscience. 142:71-85
50. Delmas P, Abogadie FC, Milligan G et al (1999) β? Dimers derived from Go and Gi proteins contribute different components of adrenergic inhibition of Ca2+ channels in rat sympathetic neurons. J Physiol 518:23-36
51. Diniz C, Leal S, Goncalves J (2003) Regional differences in the adenosine A2 receptor-mediated modulation of contractions in rat vas deferens. Eur J Pharmacol 460:191-9
52. Diogenes MJ, Fernandes CC, Sebastiao AM et al (2004) Activation of adenosine A2A receptor facilitates brain-derived neurotrophic factor modulation of synaptic transmission in hippocampal slices. J Neurosci 24:2905-13
53. Diverse-Pierluissi M, Dunlap K, Westhead EW (1991) Multiple actions of extracellular ATP on calcium currents in cultured bovine chromaffin cells. Proc Natl Acad Sci USA 88:1261-5
54. Dixon AK, Gubitz AK, Sirinathsinghji DJ et al (1996) Tissue distribution of adenosine receptor mRNAs in the rat. Br J Pharmacol 118:1461-8
55. Dixon AK, Widdowson L, Richardson PJ (1997) Desensitization of the adenosine A1 receptor by the A2A receptor in the rat striatum. J Neurochem 69:315-21
56. Dolphin AC (2003) G protein modulation of voltage-gated calcium channels. Pharmacol Rev 55:607-27
57. Dolphin AC, Archer ER (1983) An adenosine agonist inhibits and a cyclic AMP analogue enhances the release of glutamate but not GABA from slices of rat dentate gyrus. Neurosci Lett 43:49-54
58. Dolphin AC, Forda SR, Scott RH (1986) Calcium-dependent currents in cultured rat dorsal root ganglion neurones are inhibited by an adenosine analogue. J Physiol 373:47-61
59. Duarte-Araujo M, Nascimento C, Timoteo MA et al (2004) Dual effects of adenosine on acetylcholine release from myenteric motoneurons are mediated by junctional facilitatory A2A and extrajunctional inhibitory A1 receptors. Br J Pharmacol 141:925-34
60. Dunwiddie TV, Fredholm BB (1984) Adenosine receptors mediating inhibitory electrophysiological responses in rat hippocampus are different from receptors mediating cyclic AMP accumulation. Naunyn Schmiedeberg's Arch Pharmacol 326:294-301
61. Dunwiddie TV, Hoffer BJ, Fredholm BB (1981) Alkylxanthines elevate hippocampal excitability. Evidence for a role of endogenous adenosine. Naunyn-Schmiedeberg's Arch Pharmacol 316:326-30
62. Dunwiddie TV, Worth TS, Olsson RA (1986) Adenosine analogs mediating depressant effects on synaptic transmission in rat hippocampus: structure-activity relationships for the N6 subregion. Naunyn Schmiedeberg's Arch Pharmacol 334:77-85
63. Ebstein RP, Daly JW (1982) Release of norepinephrine and dopamine from brain vesicular preparations: effects of adenosine analogues. Cell Mol Neurobiol 2:193-204
64. Enero MA, Saidman BQ (1977) Possible feed-back inhibition of noradrenaline release by purine compounds. Naunyn-Schmiedeberg's Arch Pharmacol 297:39-46
65. Fastbom J, Pazos A, Probst A et al (1986) Adenosine A1-receptors in human brain: characterization and autoradiographic visualization. Neurosci Lett 65:127-32
66. Feoktistov I, Biaggioni I (1997) Adenosine A2B receptors. Pharmacol Rev 49:381-402
67. Ferre S, Karcz-Kubicha M, Hope BT et al (2002) Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: Implications for striatal neuronal function. Proc Natl Acad Sci USA 99:11940-5
68. Feuerstein TJ, Hertting G, Jackisch R (1985) Modulation of hippocampal serotonin (5-HT) release by endogenous adenosine. Eur J Pharmacol 107:233-42
69. Filippov AK, Simon J, Barnard EA et al (2003) Coupling of the nucleotide P2Y4 receptor to neuronal ion channels. Br J Pharmacol 138:400-6
70. Filippov AK, Fernandez-Fernandez JM, Marsh SJ et al (2004) Activation and inhibition of neuronal G protein-gated inwardly rectifying K+ channels by P2Y nucleotide receptors. Mol Pharmacol 66:468-77
71. Forsyth KM, Bjur RA, Westfall DP (1991) Nucleotide modulation of norepinephrine release from sympathetic nerves in the rat vas deferens. J Pharmacol Exp Ther 1256:821-6
72. Franco R, Canela EI, Bozal J (1986) Enzymes of the purine metabolism in rat brain microsomes. Neurochem Res 11:407-22
73. Fredholm BB, Dunwiddie TV (1988) How does adenosine inhibit transmitter release? Trends Pharmacol Sci 9:130-4
74. Fredholm BB, Lindgren E (1987) Effects of N-ethylmaleimide and forskolin on noradrenaline release from rat hippocampal slices. Evidence that prejunctional adenosine and alpha-receptors are linked to N-proteins but not to adenylate cyclase. Acta Physiol Scand 130:95-105
75. Fredholm BB, Lindgren E (1988) Protein kinase C activation increases noradrenaline release from rat hippocampus and modifies the inhibitory effect of α2-adrenoceptor and adenosine A1-receptor agonists. Naunyn Schmiedeberg's Arch Pharmacol 337:477-83
76. Fredholm BB, Jonzon B, Lindgren E (1983) Inhibition of noradrenaline release from hippocampal slices by a stable adenosine analogue. Acta Physiol Scand Suppl 515:7-10
77. Fredholm BB, Fastbom J, Lindgren E (1986) Effects of N-ethylmaleimide and forskolin on glutamate release from rat hippocampal slices. Evidence that prejunctional adenosine receptors are linked to N-proteins, but not to adenylate cyclase. Acta Physiol Scand 127:381-6
78. Fredholm BB, Ijzerman AP, Jacobson KA et al (2001) Nomenclature and classification of adenosine receptors. Pharmacol Rev 53: 527-52
79. Fresco P, Diniz C, Queiroz G et al (2002) Release inhibitory receptors activation favours the A2Aadenosine receptor-mediated facilitation of noradrenaline release in isolated rat-tail artery. Br J Pharmacol 136:230-6
80. Fresco P, Diniz C, Goncalves J (2004) Facilitation of noradrenaline release by activation of adenosine A2A receptors triggers both phospholipase C and adenylate cyclase pathways in rat tail artery. Cardiovasc Res 63:739-46
81. Fuder H, Muth U (1993) ATP and endogenous agonists inhibit evoked [3H]-noradrenaline release in rat iris via A1 and P2Y-like purinoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 348:352-7
82. Fuder H, Brink A, Meincke M et al (1992) Purinoceptor-mediated modulation by endogenous and exogenous agonists of stimulation-evoked [3H]-noradrenaline release on rat iris. Naunyn Schmiedeberg's Arch Pharmacol 345:417-23
83. Fujioka M, Cheung DW (1987) Autoregulation of neuromuscular transmission in the guinea-pig saphenous artery. Eur J Pharmacol 139:147-53
84. Gamper N, Reznikov V, Yamada Y et al (2004) Phosphatidylinositol 4,5-bisphosphate signals underlie receptor-specific Gq/11-mediated modulation of N-type Ca2+ channels. J Neurosci 24:10980-992
85. Gerevich Z, Borvendeg SJ, SchroederWet al (2004) Inhibition of N type voltage-activated calcium channels in rat dorsal root ganglion neurons by P2Y receptors is a possible mechanism of ADPinduced analgesia. J Neurosci 24:797-807
86. Gerevich Z, Muller C, Illes P (2005) Metabotropic P2Y1 receptors inhibit P2X3 receptor-channels in rat dorsal ganglion neurons. Eur J Pharmacol 521:34-38
87. Gines S, Hillion J, Torvinen M et al (2000) Dopamine D1 and adenosine A1 receptors from functionally interacting heteromeric complexes. Proc Natl Acad Sci USA 97:8606-11
88. Gines S, Ciruela F, Burgueno J et al (2001) Involvement of caveolin in ligand-induced recruitment and internalization of A1 adenosine receptor and adenosine deaminase in an epithelial cell line. Mol Pharmacol 59:1314-23
89. Giniatullin RA, Sokolova EM (1998) ATP and adenosine inhibit transmitter release at the frog neuromuscular junction through distinct presynaptic receptors. Br J Pharmacol 124:839-44
90. Ginsborg BL, Hirst GD (1972) The effect of adenosine on the release of the transmitter from the phrenic nerve of the rat. J Physiol 224:629-45
91. Glass M, Faull RL, Dragunow M (1996) Localisation of the adenosine uptake site in the human brain: a comparison with the distribution of adenosine A1 receptors. Brain Res 710:79-91
92. Goncalves J, Queiroz G (1993) Facilitatory and inhibitory modulation by endogenous adenosine of noradrenaline release in the epididymal portion of rat vas deferens. Naunyn-Schmiedeberg's Arch Pharmacol 348:367-71
93. Goncalves J, Queiroz G (1996) Purinoceptor modulation of noradrenaline release in rat tail artery: tonic modulation mediated by inhibitory P2Y-and facilitatory A2A-purinoceptors. Br J Pharmacol 117:156-60
94. Goncalves J, Bultmann R, Driessen B (1996) Opposite modulation of cotransmitter release in guinea-pig vas deferens: increase of noradrenaline and decrease of ATP release by activation of prejunctional β-adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 353:184-92
95. Gray JH, Owen RP, Giacomini KM (2004) The concentrative nucleoside transporter family, SLC28. Pflugers Arch 447:728-34
96. Gross RA, Macdonald RL, Ryan-Jastrow T (1989) 2-Chloroadenosine reduces the N calcium current of cultured mouse sensory neurones in a pertussis toxin-sensitive manner. J Physiol 411:585-95
97. Gubitz AK,Widdowson L, KurokawaMet al (1996) Dual signalling by the adenosine A2a receptor involves activation of both N-and P-type calcium channels by different G proteins and protein kinases in the same striatal nerve terminals. J Neurochem 67:374-81
98. Haas HL, Greene RW (1988) Endogenous adenosine inhibits hippocampal CA1 neurones: further evidence from extra-and intracellular recording. Naunyn Schmiedeberg's Arch Pharmacol 1988 337:561-5
99. Hada J, Kaku T, Morimoto K et al (1998) Activation of adenosine A2 receptors enhances high K+-evoked taurine release from rat hippocampus: a microdialysis study. Amino Acids15:43-52
100. Hamid J, Nelson D, Spaetgens R et al (1999) Identification of an integration center for cross-talk between protein kinase C and G protein modulation of N-type calcium channels. J Biol Chem 274:6195-202
101. Harms HH,Wardeh G, Mulder AH (1979) Effect of adenosine on depolarization-induced release of various radiolabelled neurotransmitters from slices of rat corpus striatum. Neuropharmacology 18:577-80
102. Hedqvist P, Fredholm BB (1976) Effects of adenosine on adrenergic neurotransmission; prejunctional inhibition and postjunctional enhancement. Naunyn Schmiedeberg's Arch Pharmacol 293:217-23
103. Helfman CC, Zhong H, Barraco RA et al (1996) The effects of 5-N-ethylcarboxamidoadenosine on evoked release of [3H]serotonin in the rat nucleus tractus solitarius. Neurosci Lett 213:61-5
104. Hertting G, Wurster S, Allgaier C (1990) Regulatory proteins in presynaptic function. Ann N Y Acad Sci 604:289-304
105. Hillion J, Canals M, Torvinen M et al (2002) Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors. Biol Chem 277:18091-7
106. Hollins C, Stone TW (1980) Adenosine inhibition of aminobutyric acid release from slices of rat cerebral cortex. Br J Pharmacol 69:107-12
107. Hollopeter G, Jantzen HM, Vincent D et al (2001) Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 409:202-7
108. Holton FA, Holton P (1953) The possibility that ATP is a transmitter at sensory nerve endings. J Physiol 119: 50P-51P
109. Hong SJ, Chang CC (1998) Evaluation of intrinsic modulation of synaptic transmission by ATP in mouse fast twitch muscle. J Neurophysiol 80:2550-8
110. Hunt JM, Redman RS, Silinsky EM (1994) Reduction by intracellular calcium chelation of acetylcholine secretion without occluding the effects of adenosine at frog motor nerve endings. Br J Pharmacol 111:753-8
111. Hur EM, Kim KT (2002) G protein-coupled receptor signalling and cross-talk: achieving rapidity and specificity. Cell Signal 14:397-405
112. Hussl S, Boehm S (2006) Functions of neuronal P2Y receptors. Eur J Physiol 452:538-51
113. Hutchison AJ, Webb RL, Oei HH et al (1989) CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity. J Pharmacol Exp Ther 251:47-55
114. Ingall AH, Dixon J, Bailey A et al (1999) Antagonists of the platelet P2T receptor: A novel approach to antithrombotic therapy. J Med Chem 42:213-20
115. Inoue K, Koizumi S, Ueno S et al (1999) The functions of ATP receptors in the synaptic transmission in the hippocampus. Prog Brain Res 120:193-206
116. Jackisch R, Strittmatter H, Kasakov L et al (1984) Endogenous adenosine as a modulator of hippocampal acetylcholine release. Naunyn-Schmiedeberg's Arch Pharmacol 327:319-25
117. Jackisch R, Fehr R, Hertting G (1985) Adenosine: an endogenous modulator of hippocampal noradrenaline release. Neuropharmacology 24:499-507
118. Jarvis MF, Schulz R, Hutchison AJ et al (1989) [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain. J Pharmacol Exp Therap 251:888-93
119. Jeong SW, Ikeda SR (2000) Effect of G protein heterotrimer composition on coupling of neurotransmitter receptors to N-type Ca2+ channel modulation in sympathetic neurons. Proc Natl Acad Sci 97:907-12
120. Jin S, Fredholm BB (1997) Adenosine A2A receptor stimulation increases release of acetylcholine from rat hippocampus but not striatum, and does not affect catecholamine release. Naunyn-Schmiedeberg's Arch Pharmacol 355:48-56
121. Jonzon B, Fredholm BB (1984) Adenosine receptor mediated inhibition of noradrenaline release from slices of the rat hippocampus. Life Sci 35:1971-9
122. Katada T, Gilman AG, Watanabe Y et al (1985) Protein kinase C phosphorylates the inhibitory guanine-nucleotide-binding regulatory component and apparently suppresses its function in hormonal inhibition of adenylate cyclase. Eur J Biochem 151:431-7
123. Katsuragi T, Su C (1982) Augmentation by theophylline of [3H]purine release from vascular adrenergic nerves: evidence for presynaptic autoinhibition. J Pharmacol Exp Ther 220:152-6
124. Kegel B, Braun N, Heine P et al (1997) An ecto-ATPase and an ecto-ATP diphosphohydrolase are expressed in rat brain. Neuropharmacology 36:1189-1200
125. Kim YC, Ji X, Melman N et al (2000) Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A2B adenosine receptors. J Med Chem 43:1165-72
126. Kirk IP, Richardson PJ (1994) Adenosine A2a receptor-mediated modulation of striatal [3H]GABA and [3H]acetylcholine release. J Neurochem 62:960-6
127. Koch H, von Kugelgen I, Starke K (1997) P2-receptor-mediated inhibition of noradrenaline release in the rat hippocampus. Naunyn-Schmiedeberg's Arch Pharmacol 355:707-15
128. Koch H, von Kugelgen I, Starke K (1998) P2-receptor-mediated inhibition of noradrenaline release in the rat pancreas. Naunyn-Schmiedeberg's Arch Pharmacol 357:431-40
129. Koizumi S, Inoue K (1997) Inhibition by ATP of calcium oscillations in rat cultured hippocampal neurones. Br J Pharmacol 122:51-8
130. Koizumi S, Fujishita K, Tsuda M et al (2003) Dynamic inhibition of excitatory synaptic transmission by astrocyte-derived ATP in hippocampal cultures. Proc Natl Acad Sci USA 100:11023-8
131. Kubista H, Boehm S (2006) Molecular mechanisms underlying the modulation of exocytotic noradrenaline release via presynaptic receptors. Pharmacol Ther 112:213-42
132. Kukulski F, Sevigny J, Komoszynski M (2004) Comparative hydrolysis of extracellular adenine nucleotides and adenosine in synaptic membranes from porcine brain cortex, hippocampus, cerebellum and medulla oblongata. Brain Res 1030:49-56
133. Kurokawa M, Koga K, Kase H et al (1996) Adenosine A2a receptor-mediated modulation of striatal acetylcholine release in vivo. J Neurochem 66:1882-8
134. Kurz K, von Kugelgen I, Starke K (1993) Prejunctional modulation of noradrenaline release in mouse and rat vas deferens: contribution of P1-and P2-purinoceptors. Br J Pharmacol 110:1465-72
135. Latini S, Pedata F (2001) Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J Neurochem 79:463-84
136. Lechner SG, Dorostkar MM, MayerMet al (2004) Autoinhibition of transmitter release from PC12 cells and sympathetic neurons through a P2Y12 receptor-mediated inhibition of voltage-gated Ca2+ channels. Eur J Neurosci 20:2917-28
137. Lechner SG, Hussl S, Schicker KW et al (2005) Presynaptic inhibition via a phospholipase Cand phosphatidylinositol bisphosphate-dependent regulation of neuronal Ca2+ channels. Mol Pharmacol 68:1387-96
138. Liang M, Eason MG, Jewell-Motz EA et al (1998) Phosphorylation and functional desensitisation of the α2A-adrenergic receptor by protein kinase C. Mol Pharmacol 54:44-9
139. Lim W, Kim SJ, Yan HD et al (1997) Ca2+-channel dependent and-independent inhibition of exocytosis by extracellular ATP in voltage-clamped rat adrenal chromaffin cells. Pflugers Arch 435:34-42
140. Lim WK, Myung C-S, Garrison JC et al (2001) Receptor-G protein ? specificity: ?11 shows unique potency for A1 adenosine and 5-HT1A receptors. Biochemistry 40:10532-41
141. Limberger N, Spath L, Starke K (1988) Presynaptic α2-adrenoceptor, opioid receptor and adenosine A1-receptor interactions on noradrenaline release in rabbit brain cortex. Naunyn-Schmiedberg's Arch Pharmacol 338:53-61
142. Lohse MJ, Klotz KN, Lindenborn-Fotinos J et al (1987) 8-Cyclopentyl-1,3-dipropylxanthine (DPCPX)-a selective high affinity antagonist radioligand for A1 adenosine receptors. Naunyn-Schmiedeberg's Arch Pharmacol 336:204-10
143. Londos C, Preston MS (1977) Regulation of glucagon and divalent cations of inhibition of hepatic adenylate cyclase by adenosine. J Biol Chem 252:5951-6
144. Lopes LV, Cunha RA, Ribeiro JA (1999) Cross talk between A1 and A2A adenosine receptors in the hippocampus and cortex of young adult and old rats. J Neurophysiol 82:3196-3203
145. Lopes LV, Cunha RA, Kull B et al (2002) Adenosine A2A receptor facilitation of hippocampal synaptic transmission is dependent on tonic A1 receptor inhibition. Neuroscience 112:319-29
146. Lupica CR, Cass WA, Zahniser NR et al (1990) Effects of the selective adenosine A2 receptor agonist CGS 21680 on in vitro electrophysiology, cAMP formation and dopamine release in rat hippocampus and striatum. J Pharmacol Exp Therap 252:1134-41
147. Luthardt J, Borvendeg SJ, Sperlagh B et al (2003) P2Y1 receptor activation inhibits NMDA receptor-channels in layer V pyramidal neurons of the rat prefrontal and parietal cortex. Neurochem Int 42:161-72
148. Lynge J, Hellsten Y (2000) Distribution of adenosine A1, A2A and A2B receptors in human skeletal muscle. Acta Physiol Scand 169:283-90
149. MacLean DA, Sinoway LI, Leuenberger U (1998) Systemic hypoxia elevates skeletal muscle interstitial adenosine levels in humans. Circulation 98:1990-2
150. Marchi M, Raiteri L, Risso F et al (2002) Effects of adenosine A1 and A2A receptor activation on the evoked release of glutamate from rat cerebrocortical synaptosomes. Br J Pharmacol 136:434-40
151. Matsuoka I, Ohkubo S (2004) ATP-and adenosine-mediated signaling in the central nervous system: adenosine receptor activation by ATP through rapid and localized generation of adenosine by ecto-nucleotidases. J Pharmacol Sci 94: 95-9
152. Mayfield RD, Suzuki F, Zahniser NR (1993) Adenosine A2a receptor modulation of electrically evoked endogenous GABA release from slices of rat globus pallidus. J Neurochem 60:2334-7
153. Mendoza-Fernandez V, Andrew RD, Barajas-Lopez C (2000) ATP inhibits glutamate synaptic release by acting at P2Y receptors in pyramidal neurons of hippocampal slices. J Pharmacol Exp Ther 293:172-9
154. Michaelis ML, Michaelis EK, Myers SL (1979) Adenosine modulation of synaptosomal dopamine release. Life Sci 24:2083-92
155. Mihaylova-Todorova ST, Todorov LD, Westfall DP (2002) Enzyme kinetics and pharmacological characterization of nucleotidases released from the guinea pig isolated vas deferens during nerve stimulation: evidence for a soluble ecto-nucleoside triphosphate diphosphohydrolase-like ATPase and a soluble ecto-5- nucleotidase-like AMPase. J Pharmacol Exp Ther 302:992-1001
156. Moos WH, Szotek DS, Bruns RF (1985) N6-Cycloalkyladenosines. Potent A1-selective adenosine agonists. J Med Chem 28:1383-4
157. Mota A, Guimaraes S (2003) Influence of α2-autoreceptor-stimulation on the facilitation by angiotensin II and bradykinin of noradrenaline release. Naunyn-Schmiedberg's Arch Pharmacol 368:443-7
158. Muller MJ, Paton DM (1979) Presynaptic inhibitory actions of 2-substituted adenosine derivatives on neurotransmission in rat vas deferens: effects of inhibitors of adenosine uptake and deamination. Naunyn-Schmiedeberg's Arch Pharmacol 306:23-8
159. Munshi R, Pang IH, Sternweis PC et al (1991) A1 adenosine receptors of bovine brain couple to guanine nucleotide-binding proteins Gi1, Gi2, and Go. J Biol Chem 266:22285-9
160. Mynlieff M, Beam KG (1994) Adenosine acting at an A1 receptor decreases N-type calcium current in mouse motoneurons. J Neurosci 14:3628-34
161. Nagy G, Reim K, Matti U et al (2004) Regulation of releasable vesicle pool sizes by protein kinase A-dependent phosphorylation of SNAP-25. Neuron 41:417-29
162. Nakata H, Yoshioka K, Kamiya T et al (2005) Functions of heteromeric association between adenosine and P2Y receptors. J Mol Neurosci 25:233-8
163. Nakatsuka H, Nagano O, Foldes FF et al (1995) Effects of adenosine on norepinephrine and acetylcholine release from guinea pig right atrium: role of A1-receptors. Neurochem Int 27:345-53
164. Nitahara K, Kittel A, Liang SD, Vizi ES (1995) A1-receptor-mediated effect of adenosine on the release of acetylcholine from the myenteric plexus: role and localization of ecto-ATPase and 5-nucleotidase. Neuroscience 67:159-68
165. O'Kane EM, Stone TW (1998) Interaction between adenosine A1 and A2 receptor-mediated responses in the rat hippocampus in vitro. Eur J Pharmacol 362:17-25
166. Ohkubo S, Kimura J, Matsuoka I (2000) Ecto-alkaline phosphatase in NG108-15 cells: a key enzyme mediating P1 antagonist sensitive ATP response. Br J Pharmacol 131:1667-2
167. Okada M, Mizuno K, Kaneko S (1996) Adenosine A1 and A2 receptors modulate extracellular dopamine levels in rat striatum. Neurosci Lett 212:53-6
168. Okada M, Nutt DJ, Murakami T et al (2001) Adenosine receptor subtypes modulate two major functional pathways for hippocampal serotonin release. J Neurosci 21:628-40
169. Oliveira L, Correia-de-Sa P (2005) Protein kinase A and Cav1 (L-Type) channels are common targets to facilitatory adenosine A2A and muscarinic M1 receptors on rat motoneurons. Neurosignals 14:262-72
170. Olsson RA, Davies CJ, Khouri EM et al (1976) Evidence for an adenosine receptor on the surface of dog coronary myocytes. Circ Res 39:93-8
171. Ongini E, Dionisotti S, Gessi S, Irnius E, Fredholm BB (1999) Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors. Naunyn-Schmiedeberg's Arch Pharmacol 359:7-10
172. O'Regan MH, Simpson RE, Perkins LM et al (1992) The selective A2 adenosine receptor agonist CGS 21680 enhances excitatory transmitter amino acid release from the ischemic rat cerebral cortex. Neurosci Lett 138:169-72
173. Paton DM (1981) Structure-activity relations for presynaptic inhibition of noradrenergic and cholinergic transmission by adenosine: evidence for action on A1 receptors. J Auton Pharmacol 1:287-90
174. Pedata F, Antonelli T, Lambertini L et al (1983) Effect of adenosine, adenosine triphosphate, adenosine deaminase, dipyridamole and aminophylline on acetylcholine release from electrically-stimulated brain slices. Neuropharmacol 22:609-14
175. Phillis JW, Kostopoulos GK, Limacher JJ (1975) A potent depressant action of adenine derivatives on cerebral cortical neurones. Eur J Pharmacol 30:125-9
176. Popoli P, Betto P, Reggio R et al (1995) Adenosine A2A receptor stimulation enhances striatal extracellular glutamate levels in rats. Eur J Pharmacol 287:215-17
177. Poucher SM, Keddie JR, Singh P et al (1995) The in vitro pharmacology of
178. Powell AD, Teschemacher AG, Seward EP (2000) P2Y purinoceptors inhibit exocytosis in adrenal chromaffin cells via modulation of voltage-operated calcium channels. J Neurosci 20:606-16
179. Price GD, Robertson SJ, Edwards FA (2003) Long-term potentiation of glutamatergic synaptic transmission induced by activation of presynaptic P2Y receptors in the rat medial habenula nucleus. Eur J Neurosci 17:844-50
180. Quarta D, Ferre S, Solinas M et al (2004) Opposite modulatory roles for adenosine A1 and A2A receptors on glutamate and dopamine release in the shell of the nucleus accumbens. Effects of chronic caffeine exposure. J Neurochem 88:1151-8
181. Queiroz G, Gebicke-Haerter PJ, Schobert A et al (1997) Release of ATP from cultured rat astrocytes elicited by glutamate receptor activation. Neuroscience 78:1203-8
182. Queiroz G, Diniz C, Goncalves J (2002) Facilitation of noradrenaline release by adenosine A2A receptors in the epididymal portion and adenosine A2B receptors in the prostatic portion of the rat vas deferens. Eur J Pharmacol 448:45-50
183. Queiroz G, Quintas C, Talaia C et al (2004) Coupling to protein kinases A and C of adenosine A2B receptors involved in the facilitation of noradrenaline release in the prostatic portion of rat vas deferens. Neuropharmacology 47:216-24
184. Queiroz G, Talaia C, Goncalves J (2003a) Adenosine A2A receptor-mediated facilitation of noradrenaline release involves protein kinase C activation and attenuation of presynaptic inhibitory receptor-mediated effects in the rat vas deferens. J Neurochem 85:740-8
185. Queiroz G, Talaia C, Goncalves J (2003b) ATP modulates noradrenaline release by activation of inhibitory P2Y receptors and facilitatory P2X receptors in the rat vas deferens. J Pharmacol Exp Ter 307:809-15
186. Rebola R, Oliveira CR, Cunha RA (2002) Transducing system operated by adenosine A2A receptors to facilitate acetylcholine release in the rat hippocampus. Eur J Pharmacol 454:31-8
187. Reddington M, Lee KS, Schubert P (1982) An A1-adenosine receptor, characterized by [3H] cyclohexyladenosine binding, mediates the depression of evoked potentials in a rat hippocampal slice preparation. Neurosci Lett 28:275-9
188. Ribeiro JA, Sebastiao AM (1985) On the type of receptor involved in the inhibitory action of adenosine at the neuromuscular junction. Br J Pharmacol 84:911-18
189. Ribeiro JA, Sebastiao AM (1986) Adenosine receptors and calcium: basis for proposing a third (A3) adenosine receptor. Prog Neurobiol 26:179-209
190. Ribeiro JA, Sebastiao AM (1987) On the role, inactivation and origin of endogenous adenosine at the frog neuromuscular junction. J Physiol (Lond) 384: 571-85
191. Ribeiro JA, Walker J (1975) The effects of adenosine triphosphate and adenosine diphosphate on transmission at the rat and frog neuromuscular junctions. Br J Pharmacol 54:213-18
192. Ribeiro JA, Sa-Almeida AM, Namorado JM (1979) Adenosine and adenosine triphosphate decrease 45Ca uptake by synaptosomes stimulated by potassium. Biochem Pharmacol 28:1297-1300
193. Rivkees SA, Price SL, Zhou FC (1995) Immunohistochemical detection of A1 adenosine receptors in rat brain with emphasis on localization in the hippocampal formation, cerebral cortex, cerebellum, and basal ganglia. Brain Res 677:193-203
194. Robitaille R, Thomas S, Charlton MP (1999) Effects of adenosine on Ca2+ entry in the nerve terminal of the frog neuromuscular junction. Can J Physiol Pharmacol 77:707-14
195. Robson SC, Sevigny J, Zimmermann H (2006) The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance. Purinergic Signalling 2:409-30
196. Rodrigues RJ, Almeida T, Richardson PJ et al (2005) Dual presynaptic control by ATP of glutamate release via facilitatory P2X1, P2X2/3, and P2X3 and inhibitory P2Y1, P2Y2, and/or P2Y4 receptors in the rat hippocampus. J Neurosci 25:6286-95
197. Rosenberg PA, Li Y (1995) Vasoactive intestinal peptide regulates extracellular adenosine levels in rat cortical cultures. Neurosci Lett 200:93-6
198. Ruiz MA, Escriche M, Lluis C et al (2000) Adenosine A1 receptor in cultured neurons from rat cerebral cortex: colocalization with adenosine deaminase. J Neurochem 75:656-64
199. Saitoh Y, Nakata H (1996) Photoaffinity labelling of a P3 purinoceptor-like protein purified from rat brain membranes. Biochem Biophys Res Commun 219: 469-74
200. Saitow F, Suzuki H, Konishi S (2005) Beta-adrenoceptor-mediated long term up-regulation of the release machinery at rat cerebellar GABAergic synapses. J Physiol 565:487-502
201. Sattin A, Rall TW (1970) The effect of adenosine and adenine nucleotides on the cyclic adenosine 3',5'-phosphate content of guinea pig cerebral cortex slices. Mol Pharmacol 6:13-23
202. Saura CA, Mallol J, Canela EI et al (1998) Adenosine deaminase and A1 adenosine receptors internalize together following agonist-induced receptor desensitization. J Biol Chem 273:17610-17
203. Schindler M, Harris CA, Hayes B et al (2001) Immunohistochemical localization of adenosine A1 receptors in human brain regions. Neurosci Lett 297:211-15
204. Schlicker E, Gothert M (1998) Interactions between the presynaptic α2-autoreceptor and presynaptic inhibitory heteroreceptors on noradrenergic neurones. Brain Res Bull 47:129-32
205. Schubert P, Heinemann U, Kolb R (1986) Differential effect of adenosine on pre-and postsynaptic calcium fluxes. Brain Res 376:382-6
206. Sebastiao AM, Ribeiro JA (1985) Enhancement of transmission at the frog neuromuscular junction by adenosine deaminase: evidence for an inhibitory role of endogenous adenosine on neuromuscular transmission. Neurosci Lett 62:267-70
207. Sebastiao AM, Ribeiro JA (1988) On the adenosine receptor and adenosine inactivation at the rat diaphragm neuromuscular junction. Br J Pharmacol 94:109-20
208. Sebastiao A M, Ribeiro JA (2000) Fine-tuning neuromodulation by adenosine. Trends Pharmacol Sci 21:341-6
209. Sebastiao AM, Stone TW, Ribeiro JA (1990) The inhibitory adenosine receptor at the neuromuscular junction and hippocampus of the rat: antagonism by 1,3,8-substituted xanthines. Br J Pharmacol 101:453-9
210. Sebastiao AM, Cunha RA, Cascalheira JF et al (1999) Adenine nucleotides as inhibitors of synaptic transmission: role of localised ectonucleotidases. Prog Brain Res 120:183-92
211. Sebastiao AM, Macedo MP, Ribeiro JA (2000) Tonic activation of A2A adenosine receptors unmasks, and of A1 receptors prevents, a facilitatory action of calcitonin gene-related peptide in the rat hippocampus. Br J Pharmacol 129:374-80
212. Shaver SR, Rideout JL, PendergastWet al (2005) Structure-activity relationships of dinucleotides: potent and selective agonists of P2Y receptors. Purinergic Signal 1:183-91
213. Shindou T, Mori A, Kase H et al (2001) Adenosine A2A receptor enhances GABAA-mediated IPSCs in the rat globus pallidus. J Physiol 532:423-34
214. Shinozuka K, Bjur RA, Westfall DP (1988) Characterization of prejunctional purinoceptors on adrenergic nerves of the rat caudal artery. Naunyn Schmiedeberg's Arch Pharmacol 338:221-7
215. Shinozuka K, Tanioka Y, Kwon YM et al (2001) Characterization of prejunctional purinoceptors inhibiting noradrenaline release in rat mesenteric arteries. Jpn J Pharmacol 85:41-6
216. Shoji-Kasai Y, Itakura M, Kataoka M et al (2002) Protein kinase C-mediated translocation of secretory vesicles to plasma membrane and enhancement of neurotransmitter release from PC12 cells. Eur J Neurosci 15:1390-4
217. Silinsky EM (1980) Evidence for specific adenosine receptors at cholinergic nerve endings. Br J Pharmacol 71:191-4
218. Silinsky EM (2004) Adenosine decreases both presynaptic calcium currents and neurotransmitter release at the mouse neuromuscular junction. J Physiol 558:389-401
219. Silinsky EM, Ginsborg BL (1983) Inhibition of acetylcholine release from preganglionic frog nerves by ATP but not adenosine. Nature 305:327-8
220. Simon J, Filippov AK, Goransson S et al (2002) Characterization and channel coupling of the P2Y12 nucleotide receptor of brain capillary endothelial cells. J Biol Chem 277:31390-400
221. Sperlagh B, Mergl Z, Juranyi Z et al (1999) Local regulation of vasopressin and oxytocin secretion by extracellular ATP in the isolated posterior lobe of the rat hypophysis. J Endocrinol 160:343-50
222. Su C (1983) Purinergic neurotransmission and neuromodulation. Pharmacol Rev 23: 397-411
223. Su C, Bevan JA, Burnstock G (1971) [3H]adenosine triphosphate: release during stimulation of enteric nerves. Science 173:336-38
224. Talaia C, Queiroz G, Quintas C et al (2005) Interaction between adenosine A2B receptors and α2-adrenoceptors on the modulation of noradrenaline release in the rat vas deferens: possible involvement of a group 2 adenylyl cyclase isoform. Neurochem Int 47:418-29
225. Talaia C, Queiroz G, Pinheiro H et al (2006) Involvement of G-protein β? subunits on the influence of inhibitory α2-autoreceptors on the angiotensin AT1-receptor-modulation of noradrenaline release in the rat vas deferens. Neurochem Int 49:698-707
226. Ther L, Muschaweck R, Hergott J (1957) Antagonism between adenosine & methylxanthine at the bundle of His of the heart. Naunyn-Schmiedeberg's Arch Exp Pathol Pharmakol 231:586-90
227. Todorov LD, Bjur RA, Westfall DP (1994) Inhibitory and facilitatory effects of purines on transmitter release from sympathetic nerves. J Pharmacol Exp Ther 268:985-9
228. Todorov LD, Mihaylova-Todorova S, Craviso GL et al (1996) Evidence for the differential release of the cotransmitters ATP and noradrenaline from sympathetic nerves of the guinea-pig vas deferens. J Physiol 496:731-48
229. Trendelenburg AU, Bultmann R (2000) P2 receptor-mediated inhibition of dopamine release in rat neostriatum. Neuroscience 96:249-52
230. Trendelenburg AU, Meyer A, Klebroff W et al (2003) Cross talk between presynaptic angiotensin receptors, bradykinin receptors and α2- autoreceptors in sympathetic neurons: a study in α2-adrenoceptor-deficient mice. Br J Pharmacol 138:1389-1402
231. Umemiya M, Berger AJ (1994) Activation of adenosine A1 and A2 receptors differentially modulates calcium channels and glycinergic synaptic transmission in rat brainstem. Neuron 13:1439-46
232. van Calker D, Muller M, Hamprecht B (1978) Adenosine inhibits the accumulation of cyclic AMP in cultured brain cells. Nature 276:839-41
233. van Galen PJ, van Bergen AH, Gallo-Rodriguez C et al (1994) A binding site model and structureactivity relationships for the rat A3 adenosine receptor. Mol Pharmacol 45:1101-11
234. van Muijlwijk-Koezen JE, Timmerman H, van der Goot H et al (2000) Isoquinoline and quinazoline urea analogues as antagonists for the human adenosine A (3) receptor. J Med Chem 43:2227-38
235. van Schaick EA, Jacobson KA, Kim HO et al (1996) Hemodynamic effects and histamine release elicited by the selective adenosine A3 receptor agonist 2-Cl-IB-MECA in conscious rats. Eur J Pharmacol 308:311-14
236. Varani K, Merighi S, Gessi S et al (2000) [3H]MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. Mol Pharmacol 57:968-75
237. Vartian N, Boehm S (2001) P2Y receptor-mediated inhibition of voltage-activated Ca2+ currents in PC12 cells. Eur J Neurosci 13:899-908
238. Vaughan PF, Walker JH, Peers C (1998) The regulation of neurotransmitter secretion by protein kinase C. Mol Neurobiol 18:125-55
239. Verhaeghe RH, Vanhoutte PM, Shepherd JT (1977) Inhibition of sympathetic neurotransmission in canine blood vessels by adenosine and adenine nucleotides. Circ Res. 1977 40:208-15
240. Volknandt W (2002) Vesicular release mechanisms in astrocytic signalling. Neurochem Int 41: 301-6
241. von Kugelgen I (2006) Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacol Ther 110:415-32
242. von Kugelgen I, Starke K (1987) Evidence for two separate vasoconstrictor-mediating nucleotide receptors, both distinct from P2X-receptor, in rat basilar artery: a receptor for pyrimidine nucleotides and a receptor for purine nucleotides. Naunyn-Schmiedeberg's Arch Pharmacol 341:538-46
243. von Kugelgen I, Haussinger D, Starke K (1987) Evidence for a vasoconstriction-mediating receptor for UTP, distinct from the P2 purinoceptor, in rabbit ear artery. Naunyn Schmiedeberg's Arch Pharmacol 336:556-60
244. von Kugelgen I, Schoffel E, Starke K (1989) Inhibition by nucleotides acting at presynaptic P2-receptors of sympathetic neuro-efector transmission in the mouse isolated vas deferens. Naunyn-Schmiedeberg's Arch Pharmacol 340:522-32
245. von Kugelgen I, Kurz K, Starke K (1993) Axon terminal P2-purinoceptors in feedback control of sympathetic transmitter release. Neuroscience 56:263-67
246. von Kugelgen I, Kurz K, Starke K (1994) Evidence for P2-purinoceptor- mediated inhibition of noradrenaline release in rat brain cortex. Br J Pharmacol 113:815-22
247. von Kugelgen I, Stoffel D, Starke K (1995) P2-purinoceptor-mediated inhibition of noradrenaline release in rat atria. Br J Pharmacol 115:247-54
248. von Kugelgen I, Koch H, Starke K (1997) P2-receptor-mediated inhibition of serotonin release in the rat brain cortex. Neuropharmacology 36:1221-7
249. Weber RG, Jones CR, Palacios JM et al (1988) Autoradiographic visualization of A1-adenosine receptors in brain and peripheral tissues of rat and guinea pig using 125I-HPIA. Neurosci Lett 87:215-20
250. Westfall DP, Todorov LD, Mihaylova-Todorova ST (2002) ATP as a cotransmitter in sympathetic nerves and its inactivation by releasable enzymes. J Pharm Exp Ther 303:439-44
251. Wiklund NP, Gustafsson LE (1986) Neuromodulation by adenine nucleotides, as indicated by experiments with inhibitors of nucleotide inactivation. Acta Physiologica Scandinava 126:217-23
252. Wiklund NP, Gustafsson LE, Lundin J (1985) Pre-and postjunctional modulation of cholinergic neuroeffector transmission by adenine nucleotides. Experiments with agonist and antagonist. Acta Physiol Scand 125:681-91
253. Wiklund NP, Cederqvist B, Gustafsson LE (1989) Adenosine enhancement of adrenergic neuroeffector transmission in guinea-pig pulmonary artery. Br J Pharmacol 96:425-33
254. Yasuda H, Lindorfer MA, Woodfork KA et al (1996) Role of the prenyl group on the G protein ? subunit in coupling trimeric G proteins to A1 adenosine receptors. J Biol Chem 271: 18588-95
255. Yawo H, Chuhma N (1993) Preferential inhibition of omega-conotoxin- sensitive presynaptic Ca2+ channels by adenosine autoreceptors. Nature 365:256-8
256. Yoshioka K, Saitoh O, Nakata H (2002) Agonist-promoted heteromeric oligomerization between adenosine A1 and P2Y1 receptors in living cells. FEBS Lett 523:147-51
257. Zetterstrom T, Fillenz M (1990) Adenosine agonists can both inhibit and enhance in vivo striatal dopamine release. Eur J Pharmacol 180:137-43
258. Zhang FL, Luo L, Gustafson E et al (2002) P2Y13: identification and characterization of a novel Gαi-coupled ADP receptor from human and mouse. J Pharmacol Exp Ther 301:705-13
259. Zhang JM, Wang HK, Ye CH et al (2003) ATP released by astrocytes mediates glutamatergic activity-dependent heterosynaptic suppression. Neuron 40:971-82
260. Zimmermann H (1992) 5-Nucleotidase: molecular structure and functional aspects. Biochem J 285:345-65